VLA 0.00% $1.75 viralytics limited

up! up! up!

  1. 332 Posts.
    The finacial report is out, debt is under control and the testing results of the trial 5 out of 9 are know and was a success! In medicine there this is regarded as a huge success! The fact that there were no adverse side effects for the other 4 patients is likely due to other reasons other than the drug. In scientific research there is a significantly very high probability that we have a drug at hand, the sample is big enough to draw substantial conclusions!
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.